To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
This bill would amend the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish drug adherence guidelines for Medicare. The stated goal is to achieve 90 percent adherence for all Medicare Part B and Part D drugs. In developing these guidelines, the Secretary must incorporate artificial intelligence and machine learning technologies and, to the greatest extent practicable, promote the use of generic and biosimilar drugs. The measure defines what counts as Medicare Part B and Part D drugs for purposes of these guidelines. In short, if enacted, HHS would be directed to create a formal framework aimed at improving how well patients follow their medication regimens for Medicare Part B and D drugs, with a strong emphasis on technology and cost-saving drug options. The bill creates a new provision (Section 1712) within the Public Health Service Act to establish these guidelines.
Key Points
- 1Establishment of drug adherence guidelines with a target of 90 percent adherence for all Medicare Part B and Part D drugs.
- 2Requirements to use artificial intelligence and machine learning technologies in developing and applying the guidelines.
- 3Promotion of the use of generic and biosimilar drugs to the maximum extent practicable.
- 4Clear definitions of what constitutes a Medicare Part B drug and a Medicare Part D drug for purposes of the guidelines.
- 5Legislative mechanism: inserts new Section 1712 into Title XVII of the Public Health Service Act, outlining duties for the Secretary.